STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.
ORIGINAL SOURCE →via STAT News Health
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · IT
- [ENERGY] Prototype of PVT-driven dual-source heat pump with borehole thermal energy storage achieves coefficient of performance of 4.07
- [ENERGY] The Italian maxi-plant changing the energy balance in Libya
- [CONFLICT] Venice and Biennale 'shaken': 'The turmoil on the international scene has entered the exhibition'
- [SPORTS] Highlights: Brit star Boulter crashes out in round one to Lys
- [CONFLICT] Marco Rubio to meet pope at the Vatican after Trump attacks on pontiff
- [FINANCE] From the economy to culture: What makes Europeans proud?